Sign in
8-K

Current Report

CytomX Therapeutics, Inc. Filed Acc 0001193125-19-085264

Executive or director change

  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading d640154d8k.htm…